Singapore markets closed

Protara Therapeutics, Inc. (TARA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.9100+0.0200 (+0.69%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-40,420
-40,420
-65,952
-47,252
-33,978
Depreciation & amortisation
341
341
248
117
103
Stock-based compensation
6,092
6,092
6,688
10,362
9,746
Change in working capital
-4,139
-4,139
539
-516
722
Accounts payable
848
848
631
40
198
Other working capital
-37,602
-37,602
-26,577
-35,098
-24,291
Other non-cash items
1,013
1,013
1,366
1,050
-
Net cash provided by operating activities
-37,557
-37,557
-26,457
-34,502
-23,407
Cash flows from investing activities
Investments in property, plant and equipment
-45
-45
-120
-596
-884
Purchases of investments
0
-12,186
-43,550
-124,748
0
Sales/maturities of investments
2,500
65,338
58,620
27,150
0
Other investing activities
-
-
-
-
3,719
Net cash used for investing activities
53,107
53,107
14,950
-98,194
2,835
Cash flows from financing activities
Debt repayment
-
-
-
0
-1,669
Common stock issued
-
-
-
0
87,850
Common stock repurchased
-91
-91
-90
-228
0
Other financing activities
-
-
-
-
11,087
Net cash used provided by (used for) financing activities
-91
-91
-90
-228
189,401
Net change in cash
15,459
15,459
-11,597
-132,924
168,829
Cash at beginning of period
24,872
24,872
36,469
169,393
564
Cash at end of period
40,331
40,331
24,872
36,469
169,393
Free cash flow
Operating cash flow
-37,557
-37,557
-26,457
-34,502
-23,407
Capital expenditure
-45
-45
-120
-596
-884
Free cash flow
-37,602
-37,602
-26,577
-35,098
-24,291